Company profile: Myomo
1.1 - Company Overview
Company description
- Provider of myoelectric prosthetic technology to restore mobility for individuals with muscle weakness. Products include MyoPro, a powered orthosis that helps people with upper limb paralysis or weakness regain movement and functionality, and MyoPal, a device for children with upper limb weakness or paralysis to improve arm and hand function.
Products and services
- Myoelectric Prosthetic Device Development: Engineers myoelectric prosthetic devices to restore mobility for individuals with muscle weakness, focusing on movement recovery and functional use
- MyoPal: A pediatric-focused device that assists children with upper-limb weakness or paralysis by improving arm and hand function through movement support and functional assistance
- MyoPro: A powered orthosis that helps individuals with upper-limb paralysis or weakness regain movement and functionality, delivering assistive motion to support arm use and functional tasks
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Myomo
Cardinal Spine
HQ: United States
Website
- Description: Provider of an interbody fusion device: a generally rectangular vertebral body replacement (VBR) with a trapezoidal cross-section, manufactured in various heights to meet the needs of reconstructive spinal surgeons.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardinal Spine company profile →
Serf
HQ: France
Website
- Description: Provider of orthopedic implants for the hip, knee, foot, and extremities, including dual mobility and unicompartmental prosthesis, as well as medical subcontracting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Serf company profile →
LDR
HQ: United States
Website
- Description: Provider of implantable spine systems and instrumentation for spine treatments and surgeries, offering cervical and lumbar artificial disc systems, pedicle screw systems, implant systems, cervical cages, and synthetic bone substitutes; serving patients and the surgeon community in the United States and internationally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LDR company profile →
Emerge Medical
HQ: United States
Website
- Description: Provider of orthopedic devices, developed, manufactured, and distributed to reduce healthcare costs, delivering 40–60% savings to hospitals around the country by eliminating much of the unnecessary cost traditionally associated with the medical device industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emerge Medical company profile →
Elliquence
HQ: United States
Website
- Description: Provider of minimally invasive spine, interventional radiology and neurosurgical medical devices, including the Disc-FX System for disc herniations and annular tears, Trigger-Flex devices for soft tissue hemostasis, ablation and shrinkage, endoscopic spine systems for transforaminal, rhizotomy, interlaminar and stenosis procedures, the Surgi-Max Drill, and surgical training and workshops.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elliquence company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Myomo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Myomo
2.2 - Growth funds investing in similar companies to Myomo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Myomo
4.2 - Public trading comparable groups for Myomo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →